The National Cancer Institute has issued an interim guidance for all NCTN and NCORP cancer trials given the impact the COVID-19 outbreak is having on hospitals.

You can read the guidance here.

The NCI also issued another guidance for patients on Division of Cancer Prevention trials. You can read that document here.

These documents will be continually updated by the CIRB as more information becomes available. Keep checking the CIRB webpage for announcements and for their FAQ about treating patients on NCI cancer trials in the context of the coronovirus pandemic.